A clinical trial involving corticorelin was updated on August 7, 2026. The study, titled "Pelvic Pain in Women With Endometriosis," is registered under identifier NCT00073801 on ClinicalTrials.gov.
The trial's status is listed as completed. No phase information was provided in the record accessed for this update.
This update reflects only the status change recorded in the trial registry entry. No outcome data, results, or efficacy conclusions were included in this update. The completion status indicates the study has concluded, but it does not by itself indicate what, if any, findings were reported.
Corticorelin is currently categorized as an approved compound. Readers should note that trial status updates like this one document administrative or procedural changes to a study's listing rather than clinical conclusions.
Those interested in the background of this trial or its design can consult the ClinicalTrials.gov listing directly for further registry details. For general context on corticorelin, readers can consult the compound overview.